Global Kidney Cancer Therapeutics & Diagnostics Market - Segmented by Type of Cancer & Geography (2016-2021) - Research and Markets

DUBLIN--()--The "Global Kidney Cancer Therapeutics & Diagnostics Market - Segmented by type of cancer and geography (2016 - 2021)" report has been added to Research and Markets' offering.

The Kidney Cancer Market is expected to grow modestly from USD 2,264 million in 2015 at a CAGR of 3-7%.

The frequency of kidney cancer, worldwide, has increased in the recent years. Changes in lifestyle, excessive smoking, increased consumption of alcohol and a rise in obesity because of sedentary life routines lead to the growing incidence of the disease. Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of kidney cancer. About 9 out of 10 kidney cancers are renal cell carcinomas.

North America region has the largest share in the global kidney cancer drugs market. Rising numbers of kidney cancer cases and other kidney diseases is the major element driving the growth in this region. However, Asia-Pacific is expected to be the most rewarding market during the forecast period. Growing patient awareness, lower cost of drug production and the rising patient base suffering from diseases such as renal cell carcinoma are anticipated to drive the growth of the market in this region.

Some of the key participants in the industry include Pfizer, GlaxoSmithKline, Sanofi S.A, Roche, Novartis, Bayer, Abbott Laboratories, Genentech etc.

Drivers:

  • Increasing kidney cancer cases
  • Technological developments
  • Drug innovations with regard to the kidney cancer
  • Government initiatives
  • Rise in aging populace
  • Advanced health care
  • Upsurge in awareness about kidney diseases and their existing therapies in the market
  • Increasing health care expenditure

Restraints:

  • Rise in number of patent expirations
  • Rise in use of generic drugs
  • Low success rate in clinical trials
  • Regulatory affairs

Companies Mentioned

  • Bayer
  • Hoffmann La Roche
  • GlaxoSmithKline
  • Novartis
  • Pfizer
  • Abbott Laboratories
  • Amgen
  • Genentech
  • Cerulean Pharma
  • Seattle Genetics

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Porters Five Force Analysis

5. Market Segmentation

6. Competitive Landscape

7. Company Profiles

8. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/xzttfz/global_kidney

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Kidney Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Kidney Cancer Drugs